Optimi Health Corp
CNSX:OPTI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fulcrum Metals PLC
LSE:FMET
|
UK |
|
Nokia Oyj
LSE:0K8D
|
FI |
Optimi Health Corp
Research & Development
Optimi Health Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
Optimi Health Corp
CNSX:OPTI
|
Research & Development
-CA$347.7k
|
CAGR 3-Years
-38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Psyched Wellness Ltd
CNSX:PSYC
|
Research & Development
-CA$1.7m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Optimi Health Corp
Glance View
Optimi Health Corp. engages in the development, cultivation, extraction, processing, and distribution of functional mushrooms. The company is headquartered in Vancouver, British Columbia and currently employs 9 full-time employees. The company went IPO on 2021-02-25. The firm intends to cultivate, extract, process and distribute strains of fungi products, including psilocybin mushrooms, at its combined 20,000 square foot cultivation and processing facilities located in Princeton, British Columbia. Its range of fungi varieties includes Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps.
See Also
What is Optimi Health Corp's Research & Development?
Research & Development
-347.7k
CAD
Based on the financial report for Sep 30, 2025, Optimi Health Corp's Research & Development amounts to -347.7k CAD.
What is Optimi Health Corp's Research & Development growth rate?
Research & Development CAGR 3Y
-38%
Over the last year, the Research & Development growth was -141%. The average annual Research & Development growth rates for Optimi Health Corp have been -38% over the past three years .
